Cost-effectiveness of post-transplantation quality of life intervention among kidney recipients

Clinical Transplantation
Cyril F ChangDonna K Hathaway

Abstract

The purpose was to demonstrate the cost-effectiveness of an experimental post-transplant care program designed to improve kidney transplant recipients' quality of life (QoL). The intervention program integrated a three-pronged interdisciplinary approach emphasizing: (i) proactive, patient-initiated care to prevent transplant-related morbidities, (ii) employment/vocational counseling, and (iii) enhancement of social support. A cost-effectiveness analysis of a clinical trial was performed comparing QoL and costs in two groups: a retrospective cohort (n = 30) and those who received the experimental interventions (n = 150). Data were collected at baseline, 6 and 12 months. The number of quality-adjusted 'treatment-free days' was used as the primary outcome. The costs included those for direct intervention, direct inpatient and outpatient post-transplant health care, and indirect out-of-pocket expenses borne by patients. Patients in the intervention group had more quality-adjusted treatment-free days (289 vs. 272 and statistically significant) and lower cost per patient (although not statistically significant). Further, the superior outcome was delivered at an incremental cost of 29 US dollars per quality-adjusted treatment-free day...Continue Reading

References

Oct 1, 1992·Transplantation·J D RussellD N Churchill
Oct 1, 1985·ANS. Advances in Nursing Science·C E Ferrans, M J Powers
Jan 1, 1995·International Journal of Technology Assessment in Health Care·I Karlberg, G Nyberg
Jul 1, 1996·Kidney International·A LaupacisN Muirhead
Oct 9, 1996·JAMA : the Journal of the American Medical Association·L B RussellM C Weinstein
Sep 1, 1996·Journal of Transplant Coordination : Official Publication of the North American Transplant Coordinators Organization (NATCO)·D J Thomas
Apr 9, 1998·The Surgical Clinics of North America·R W Evans, D J Kitzmann
May 7, 1998·Health Policy·G A de WitF T de Charro
Apr 17, 1999·Journal of Transplant Coordination : Official Publication of the North American Transplant Coordinators Organization (NATCO)·R P Winsett
Feb 24, 2001·Progress in Transplantation : Official Publication, North American Transplant Coordinators Organization ... [et Al.]·K LewisK Hathaway
Apr 16, 2002·Progress in Transplantation : Official Publication, North American Transplant Coordinators Organization ... [et Al.]·P A GoedeckeA O Gaber

❮ Previous
Next ❯

Citations

Jul 7, 2010·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·James R RodrigueMartha Pavlakis
Feb 24, 2006·HIV Medicine·S BhaganiUNKNOWN British HIV Association
Feb 2, 2010·Seminars in Nephrology·Elisa J GordonJohn Franklin
Mar 4, 2008·Clinical Transplantation·Emily PetersenAlexander S Goldfarb-Rumyantzev
Aug 5, 2008·Clinical Transplantation·Elisa J GordonAshwini R Sehgal
Nov 10, 2015·The Journal of Nursing Research : JNR·Chiu-Yueh HsiaoFu-Mian Tsai
Oct 2, 2007·Advances in Chronic Kidney Disease·Fabienne DobbelsRichard N Fine
May 8, 2014·Journal of Health Psychology·Paola Gremigni, Gianni Cappelli
Oct 12, 2018·Khirurgiia·A S KondrashkinM Sh Khubutiya
May 31, 2019·Transplant International : Official Journal of the European Society for Organ Transplantation·Bassem HamandiEmmanuel A Papadimitropoulos
Feb 23, 2020·International Journal of Environmental Research and Public Health·Galateja JordakievaJasminka Godnic-Cvar
Apr 30, 2005·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Elisa J GordonAshwini R Sehgal

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.